The FDA has issued an approvable letter for a mammography CAD device developed by Kodak. Approvable letters usually precede final FDA consent for marketing, provided certain criteria are met. Kodak plans to offer the CAD technology as a stand-alone
The FDA has issued an approvable letter for a mammography CAD device developed by Kodak. Approvable letters usually precede final FDA consent for marketing, provided certain criteria are met. Kodak plans to offer the CAD technology as a stand-alone product and as a component of its digital capture and image-and-information management systems. According to the company, clinical trial results submitted to the FDA suggest that 39.4% of missed breast cancers would be detected 14.8 months earlier if Kodak's new technology were used.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.